Revisiting HIV-1 uncoating

Retrovirology

Volumn 7, Issue , 2010, Pages

  Arhel, Nathalie ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN TNPO3; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS NUCLEOPROTEIN; VIRUS RNA; CAPSID PROTEIN;

ANTIVIRAL THERAPY; CELL DIVISION; CELL FATE; COMPLEX FORMATION; ENDOCYTOSIS; ENZYMATIC DEGRADATION; EXPERIMENTAL MODEL; GENETIC ASSOCIATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LENTIVIRINAE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR IMPORT; PROTEIN FUNCTION; REVERSE TRANSCRIPTION; REVIEW; STRUCTURE ANALYSIS; TREATMENT PLANNING; VIRAL PHENOMENA AND FUNCTIONS; VIRION; VIRUS CAPSID; VIRUS CORE; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS GENOME; VIRUS INACTIVATION; VIRUS MORPHOGENESIS; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS UNCOATING; VIRUS VIRULENCE; CHEMISTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

CAPSID; CAPSID PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; VIRULENCE; VIRUS INTEGRATION; VIRUS UNCOATING;

EID: 78349297963     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-96     Document Type: Review

References (95)

1. Höglund S, Ofverstedt LG, Nilsson A, Lundquist P, Gelderblom H, Ozel M, Skoglund U. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res Hum Retroviruses 1992, 8:1-7. 10.1089/aid.1992.8.1, 1736937.
2. Welker R, Hohenberg H, Tessmer U, Huckhagel C, Kräusslich HG. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol 2000, 74:1168-1177. 10.1128/JVI.74.3.1168-1177.2000, 111451, 10627527.
3. Briggs JA, Wilk T, Welker R, Kräusslich HG, Fuller SD. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J 2003, 22:1707-1715. 10.1093/emboj/cdg143, 152888, 12660176.
4. Benjamin J, Ganser-Pornillos BK, Tivol WF, Sundquist WI, Jensen GJ. Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. J Mol Biol 2005, 346:577-588. 10.1016/j.jmb.2004.11.064, 15670606.
5. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science 1999, 283:80-83. 10.1126/science.283.5398.80, 9872746.
6. Li S, Hill CP, Sundquist WI, Finch JT. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 2000, 407:409-413. 10.1038/35030177, 11014200.
7. Ganser-Pornillos BK, Cheng A, Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 2007, 131:70-79. 10.1016/j.cell.2007.08.018, 17923088.
8. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell 2009, 137:1282-1292. 10.1016/j.cell.2009.04.063, 2840706, 19523676.
9. Vogt VM. Retroviral virions and genomes. 1997, 27-69. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press, Coffin JM, Hughes SH, Varmus HE.
10. Wiegers K, Rutter G, Kottler H, Tessmer U, Hohenberg H, Krausslich HG. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol 1998, 72:2846-2854. 109729, 9525604.
11. Krausslich HG, Facke M, Heuser AM, Konvalinka J, Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol 1995, 69:3407-3419. 189053, 7745687.
12. Li F, Goila-Gaur R, Salzwedel K, Kilgore NR, Reddick M, Matallana C, Castillo A, Zoumplis D, Orenstein JM, Allaway GP, Freed EO, Wild CT. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc Natl Acad Sci USA 2003, 100:13555-13560. 10.1073/pnas.2234683100, 263852, 14573704.
13. Zhou J, Yuan X, Dismuke D, Forshey BM, Lundquist C, Lee KH, Aiken C, Chen CH. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J Virol 2004, 78:922-929. 10.1128/JVI.78.2.922-929.2004, 368845, 14694123.
14. Forshey BM, von Schwedler U, Sundquist WI, Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol 2002, 76:5667-5677. 10.1128/JVI.76.11.5667-5677.2002, 137032, 11991995.
15. Gartner S, Markovits P, Markovitz DM, Betts RF, Popovic M. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 1986, 256:2365-2371. 10.1001/jama.256.17.2365, 3490587.
16. Weinberg JB, Matthews TJ, Cullen BR, Malim MH. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med 1991, 174:1477-1482. 10.1084/jem.174.6.1477, 2119042, 1720811.
17. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci USA 1992, 89:6580-6584. 10.1073/pnas.89.14.6580, 49545, 1631159.
18. Roe T, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993, 12:2099-2108. 413431, 8491198.
19. Bowerman B, Brown PO, Bishop JM, Varmus HE. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev 1989, 3:469-478. 10.1101/gad.3.4.469, 2721960.
20. Katz RA, Greger JG, Boimel P, Skalka AM. Human immunodeficiency virus type 1 DNA nuclear import and integration are mitosis independent in cycling cells. J Virol 2003, 77:13412-13417. 10.1128/JVI.77.24.13412-13417.2003, 296078, 14645598.
21. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60. 10.1016/j.cell.2008.07.032, 2628946, 18854154.
22. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101:173-85. 10.1016/S0092-8674(00)80828-4, 10786833.
23. Bouyac-Bertoia M, Dvorin JD, Fouchier RA, Jenkins Y, Meyer BE, Wu LI, Emerman M, Malim MH. HIV-1 infection requires a functional integrase NLS. Mol Cell 2001, 7:1025-1035. 10.1016/S1097-2765(01)00240-4, 11389849.
24. Ao Z, Yao X, Cohen EA. Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system. J Virol 2004, 78:3170-3177. 10.1128/JVI.78.6.3170-3177.2004, 353776, 14990738.
25. Arhel N, Munier S, Souque P, Mollier K, Charneau P. Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type. J Virol 2006, 80:10262-10269. 10.1128/JVI.00974-06, 1617309, 17005705.
26. Fuller BG. Self-organization of intracellular gradients during mitosis. Cell Div 2010, 5:5. 10.1186/1747-1028-5-5, 2829544, 20181052.
27. Kalab P, Heald R. The RanGTP gradient - a GPS for the mitotic spindle. J Cell Sci 2008, 121:1577-1586. 10.1242/jcs.005959, 18469014.
28. Karageorgos L, Li P, Burrell C. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res Hum Retroviruses 1993, 9:817-823. 10.1089/aid.1993.9.817, 7504934.
29. Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M. Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 2006, 3:4. 10.1186/1742-4690-3-4, 1360674, 16409631.
30. Farnet CM, Haseltine WA. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J Virol 1991, 65:1910-1915. 240011, 2002549.
31. Miller MD, Farnet CM, Bushman FD. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 1997, 71:5382-5390. 191777, 9188609.
32. Bukrinsky M. A hard way to the nucleus. Mol Med 2004, 10:1-5. 1431348, 15502876.
33. Lehmann-Che J, Saïb A. Early stages of HIV replication: how to hijack cellular functions for a successful infection. AIDS Rev 2004, 6:199-207.
34. Suzuki Y, Craigie R. The road to chromatin - nuclear entry of retroviruses. Nat Rev Microbiol 2007, 5:187-196. 10.1038/nrmicro1579, 17304248.
35. Dvorin JD, Malim MH. Intracellular trafficking of HIV-1 cores: journey to the center of the cell. Curr Top Microbiol Immunol 2003, 281:179-208.
36. Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, Taylor I. High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 2004, 431:481-485. 10.1038/nature02915, 15386017.
37. Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci USA 1993, 90:6125-6129. 10.1073/pnas.90.13.6125, 46880, 7687060.
38. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 1994, 91:7311-7315. 10.1073/pnas.91.15.7311, 44389, 8041786.
39. Fassati A, Goff SP. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol 2001, 75:3626-3635. 10.1128/JVI.75.8.3626-3635.2001, 114854, 11264352.
40. Grewe C, Beck A, Gelderblom HR. HIV: early virus-cell interactions. J Acquir Immune Defic Syndr 1990, 3:965-974.
41. Warrilow D, Tachedjian G, Harrich D. Maturation of the HIV reverse transcription complex: putting the jigsaw together. Rev Med Virol 2009, 19:324-337. 10.1002/rmv.627, 19750561.
42. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ. Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002, 159:441-452. 10.1083/jcb.200203150, 2173076, 12417576.
43. Nermut MV, Fassati A. Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J Virol 2003, 77:8196-8206. 10.1128/JVI.77.15.8196-8206.2003, 165229, 12857888.
44. Goff SP. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways. J Gene Med 2001, 3:517-528. 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E, 11778899.
45. Klarmann GJ, Schauber CA, Preston BD. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J Biol Chem 1993, 268:9793-9802.
46. Dismuke DJ, Aiken C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J Virol 2006, 80:3712-3720. 10.1128/JVI.80.8.3712-3720.2006, 1440469, 16571788.
47. Arhel NJ, Souquere-Besse S, Munier S, Souque P, Guadagnini S, Rutherford S, Prévost MC, Allen TD, Charneau P. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J 2007, 26:3025-3037. 10.1038/sj.emboj.7601740, 1894778, 17557080.
48. Yamashita M, Perez O, Hope TJ, Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog 2007, 3:1502-1510. 10.1371/journal.ppat.0030156, 2042020, 17967060.
49. Telesnitsky A, Goff SP. Reverse transcriptase and the generation of retroviral DNA. Retroviruses 1997, 121-160. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press, Coffin JM, Hughes SH, Varmus HE.
50. Basu VP, Song M, Gao L, Rigby ST, Hanson MN, Bambara RA. Strand transfer events during HIV-1 reverse transcription. Virus Res 2008, 134:19-38. 10.1016/j.virusres.2007.12.017, 18279992.
51. Ellison V, Abrams H, Roe T, Lifson J, Brown P. Human immunodeficiency virus integration in a cell-free system. J Virol 1990, 64:2711-2715. 249450, 2335814.
52. Farnet CM, Haseltine WA. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc Natl Acad Sci USA 1990, (87):4164-4168. 10.1073/pnas.87.11.4164, 54068, 2349226.
53. Charneau P, Alizon M, Clavel F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 1992, 66:2814-2820. 241038, 1560526.
54. Charneau P, Mirambeau G, Roux P, Paulous S, Buc H, Clavel F. HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol 1994, 241:651-662. 10.1006/jmbi.1994.1542, 7520946.
55. Kim SY, Byrn R, Groopman J, Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol 1989, 63:3708-3713. 250962, 2760980.
56. Barbosa P, Charneau P, Dumey N, Clavel F. Kinetic analysis of HIV-1 early replicative steps in a coculture system. AIDS Res Hum Retroviruses 1994, 10:53-59. 10.1089/aid.1994.10.53, 8179964.
57. Llano M, Vanegas M, Fregoso O, Saenz D, Chung S, Peretz M, Poeschla EM. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 2004, 78:9524-9537. 10.1128/JVI.78.17.9524-9537.2004, 506940, 15308744.
58. Emiliani S, Mousnier A, Busschots K, Maroun M, Van Maele B, Tempé D, Vandekerckhove L, Moisant F, Ben-Slama L, Witvrouw M, Christ F, Rain JC, Dargemont C, Debyser Z, Benarous R. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J Biol Chem 2005, 280:25517-25523. 10.1074/jbc.M501378200, 15855167.
59. Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 2005, 11:1287-1289. 10.1038/nm1329, 16311605.
60. Borroto-Esoda K, Boone LR. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction. J Virol 1991, 65:1952-1959. 240025, 1705993.
61. Thomas JA, Ott DE, Gorelick RJ. Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions. J Virol 2007, 81:4367-4370. 10.1128/JVI.02357-06, 1866140, 17267494.
62. Maréchal V, Clavel F, Heard JM, Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol 1998, 72:2208-2212. 109517, 9499078.
63. Risco C, Menéndez-Arias L, Copeland TD, Pinto da Silva P, Oroszlan S. Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. J Cell Sci 1995, 108:3039-3050.
64. Arhel NJ, Souquere-Besse S, Charneau P. Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels. Retrovirology 2006, 3:38. 10.1186/1742-4690-3-38, 1538615, 16800894.
65. Allen TD, Rutherford SA, Murray S, Gardiner F, Kiseleva E, Goldberg MW, Drummond SP. Visualization of the nucleus and nuclear envelope in situ by SEM in tissue culture cells. Nat Protoc 2007, 2:1180-1184. 10.1038/nprot.2007.139, 17546013.
66. Aiken C. Cell-free assays for HIV-1 uncoating. Methods Mol Biol 2009, 485:41-53. full_text, 19020817.
67. Wacharapornin P, Lauhakirti D, Auewarakul P. The effect of capsid mutations on HIV-1 uncoating. Virology 2007, 358:48-54. 10.1016/j.virol.2006.08.031, 16996553.
68. Brun S, Solignat M, Gay B, Bernard E, Chaloin L, Fenard D, Devaux C, Chazal N, Briant L. VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability. Retrovirology 2008, 5:57. 10.1186/1742-4690-5-57, 2474847, 18605989.
69. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA 2006, 103:5514-5519. 10.1073/pnas.0509996103, 1459386, 16540544.
70. Perron MJ, Stremlau M, Lee M, Javanbakht H, Song B, Sodroski J. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol 2007, 81:2138-2148. 10.1128/JVI.02318-06, 1865943, 17135314.
71. Li Y, Kar AK, Sodroski J. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. J Virol 2009, 83:10951-10962. 10.1128/JVI.00682-09, 2772774, 19656870.
72. Javanbakht H, Diaz-Griffero F, Yuan W, Yeung DF, Li X, Song B, Sodroski J. The ability of multimerized cyclophilin A to restrict retrovirus infection. Virology 2007, 367:19-29. 10.1016/j.virol.2007.04.034, 2065756, 17574642.
73. Diaz-Griffero F, Kar A, Lee M, Stremlau M, Poeschla E, Sodroski J. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 2007, 369:400-410. 10.1016/j.virol.2007.08.032, 2153441, 17920096.
74. Nisole S, Stoye JP, Saïb A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005, 3:799-808. 10.1038/nrmicro1248, 16175175.
75. Towers GJ. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007, 4:40. 10.1186/1742-4690-4-40, 1906832, 17565686.
76. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853. 10.1038/nature02343, 14985764.
77. Neil S, Bieniasz P. Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 2009, 29:569-580. 10.1089/jir.2009.0077, 2956573, 19694548.
78. Sebastian S, Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40. 10.1186/1742-4690-2-40, 1166576, 15967037.
79. Forshey BM, Shi J, Aiken C. Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells. J Virol 2005, 79:869-875. 10.1128/JVI.79.2.869-875.2005, 538572, 15613315.
80. Goff SP. Retrovirus restriction factors. Mol Cell 2004, 16:849-859. 10.1016/j.molcel.2004.12.001, 15610729.
81. Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 2004, 5:1109-1115. 10.1038/ni1125, 15496950.
82. Stevenson M. TRIMming HIV-1's mainsail. Nat Immunol 2004, 5:355-356. 10.1038/ni0404-355, 15052262.
83. Goff SP. HIV: replication trimmed back. Nature 2004, 427:791-793. 10.1038/427791a, 14985742.
84. Black LR, Aiken C. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro. J Virol 2010, 84:6564-6569. 10.1128/JVI.00210-10, 20410272.
85. Fassati A. HIV infection of non-dividing cells: a divisive problem. Retrovirology 2006, 3:74. 10.1186/1742-4690-3-74, 1635064, 17067381.
86. Yamashita M, Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J Virol 2004, 78:5670-5678. 10.1128/JVI.78.11.5670-5678.2004, 415837, 15140964.
87. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-6. 10.1126/science.1152725, 18187620.
88. Christ F, Thys W, De Rijck J, Gijsbers R, Albanese A, Arosio D, Emiliani S, Rain JC, Benarous R, Cereseto A, Debyser Z. Transportin-SR2 imports HIV into the nucleus. Curr Biol 2008, 18:1192-1202. 10.1016/j.cub.2008.07.079, 18722123.
89. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol 2010, 84:397-406. 10.1128/JVI.01899-09, 2798409, 19846519.
90. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7:221-233. 10.1016/j.chom.2010.02.007, 20227665.
91. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF. Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat Cell Biol 2001, 3:1092-1100. 10.1038/ncb1201-1092, 11781571.
92. Ojala PM, Sodeik B, Ebersold MW, Kutay U, Helenius A. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol Cell Biol 2000, 20:4922-4931. 10.1128/MCB.20.13.4922-4931.2000, 85943, 10848617.
93. Briones MS, Dobard CW, Chow SA. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core. J Virol 2010, 84:5181-5190. 10.1128/JVI.02382-09, 2863833, 20219923.
94. Misumi S, Inoue M, Dochi T, Kishimoto N, Hasegawa N, Takamune N, Shoji S. Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. J Biol Chem 2010, 285:25185-25195. 10.1074/jbc.M110.114256, 2919081, 20529865.
95. Auewarakul P, Wacharapornin P, Srichatrapimuk S, Chutipongtanate S, Puthavathana P. Uncoating of HIV-1 requires cellular activation. Virology 2005, 337:93-101. 10.1016/j.virol.2005.02.028, 15882886.